Fingerprint
Dive into the research topics where Priyanka Mehta is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Researchers
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 2 Journal article
-
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations
Russell, N. H., Wilhelm-Benartzi, C., Othman, J., Dillon, R., Knapper, S., Batten, L. M., Canham, J., Hinson, E. L., Betteridge, S., Overgaard, U. M., Gilkes, A., Potter, N., Mehta, P., Kottaridis, P., Cavenagh, J., Hemmaway, C., Arnold, C., Freeman, S. D., Dennis, M. & UK NCRI AML Working Group, 1. Apr 2024, In: Journal of Clinical Oncology. 42, 10, p. 1158-1168Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile83 Downloads (Pure) -
Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trial
Freeman, S. D., Thomas, A., Thomas, I., Hills, R. K., Vyas, P., Gilkes, A., Metzner, M., Jakobsen, N. A., Kennedy, A., Moore, R., Almuina, N. M., Burns, S., King, S., Andrew, G., Gallagher, K. M. E., Sellar, R. S., Cahalin, P., Weber, D., Dennis, M. & Mehta, P. & 2 others, , 16. Nov 2023, In: Blood. 142, 20, p. 1697-1707Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile63 Downloads (Pure)